Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

RCUS — Arcus Biosciences, Inc. Dilution Risk Tracker

Track RCUS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RCUS — Get alerts when the score changes →

As of October 13, 2026, Arcus Biosciences, Inc. (RCUS) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Arcus Biosciences, Inc. has a market capitalization of $3.10B, 127.33M shares outstanding, 213 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
85
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔔 Track RCUS — Get forecast alerts →

Market Data

Market Cap$3.10B
Shares Outstanding127.33M
Float89.09M
Cash$150.00M
Debt$101.00M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding127.33MVerified float table or market cache
Public Float89.09MVerified float table or market cache
Market Cap$3.10BMarket data cache
Cash Runway4.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 5.4% shares (2026Q1 vs prior)
213 institutional holders · 135.53M shares
#1 GILEAD SCIENCES, INC. 31.42M shares
#2 BlackRock, Inc. 15.23M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 7.71M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.11M
Days to Cover7.6
% of Float14.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-02-25
4 INSIDER TRANSACTION 2026-01-26
4 INSIDER TRANSACTION 2026-01-26
4 INSIDER TRANSACTION 2026-01-26
4 INSIDER TRANSACTION 2026-01-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RCUS Dilution Snapshot

Arcus Biosciences, Inc. (RCUS) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RCUS's DilutionScore is currently 50/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 35/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202650/100MEDIUM53 days
Jul 16 – Aug 21, 202635/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RCUS shares outstanding have increased 0.1% from 125.63M (Apr 2026) to 125.77M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026125.77M89.09M▲ 0.01%
May 10, 2026125.77M89.08M▲ 0.05%
May 08, 2026125.77M89.03M▲ 0.34%
Apr 28, 2026125.63M88.73M▲ 0.09%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RCUS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RCUS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RCUS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RCUS
RCUS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.